RPG Life Sciences: Certificate of Compliance Filed Under SEBI Regulations
RPG Life Sciences Limited received a compliance certificate from its Registrar and Transfer Agents, MUFG Intime India Private Limited. The certificate confirms adherence to SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025, regarding the dematerialisation of securities.
This is a routine compliance filing related to the company's share registry management and dematerialisation process. It does not involve any new business developments, financial performance changes, or strategic shifts that would significantly impact the company's operations or stock.
The announcement is a routine regulatory filing confirming compliance with SEBI regulations regarding the dematerialisation of securities, which is a standard operational procedure and does not indicate any significant positive or negative development for the company.
RPG Life Sciences Limited has submitted a certificate confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate, dated January 06, 2026, was issued by MUFG Intime India Private Limited, the company's Registrar and Transfer Agents. This confirmation pertains to the dematerialisation of securities processed during the quarter ended December 31, 2025. MUFG Intime India Private Limited confirmed that securities received from depository participants for dematerialisation were processed and listed on the stock exchanges within the prescribed timelines. They also confirmed that the security certificates were mutilated and cancelled after verification, and the depositories were substituted as the registered owners in the company's register of members.
What to do with a filing like this
RPG Life Sciences Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by RPG Life Sciences Limited. Read the original for the full detail.